{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T07:14:45Z","timestamp":1772349285964,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>Autoantibodies are biomarkers for autoimmune disease diagnosis, monitoring, and prediction. Therefore, this study established the frequency of latent and overt polyautoimmunity in children and adolescents with &gt;6 months of diagnosis of immune thrombocytopenia (ITP). Forty-seven patients with chronic or persistent disease had non\u2013organ-specific and organ-specific autoantibodies assessed. Frequency of latent polyautoimmunity was 36.2%, and, of overt polyautoimmunity, it was 4.3%. Of ITP patients with latent polyautoimmunity, 52.9% were positive for antinuclear antibody (ANA), 47.1% for autoantibodies other than ANA, and 64.7% for multiple autoantibodies. In addition, patients with latent polyautoimmunity and those positive for ANA were significantly older at disease onset. Both ITP patients positive and negative for autoantibodies reported family members with autoimmune diseases. The autoantibodies observed were as follows: ANA, anti-dsDNA, anti-SSA\/Ro, IgM aCL, anti-GAD, anti-IA2, anti-IAA, anti-TG, anti-TPO, anti-LKM1, and SMA. Of ITP patients with overt polyautoimmunity, 1 was diagnosed with type 1 diabetes mellitus and the other with thyroiditis. In conclusion, children and adolescents with ITP present high frequency of latent and overt polyautoimmunity even for autoantibodies other than ANA. Therefore, ANA and other non\u2013organ-specific and organ-specific autoantibodies should be considered for assessment during ITP patients\u2019 follow-up.<\/jats:p>","DOI":"10.1097\/mph.0000000000001836","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T15:47:38Z","timestamp":1590594458000},"page":"e606-e609","source":"Crossref","is-referenced-by-count":12,"title":["Latent and Overt Polyautoimmunity in Children and Adolescents With Immune Thrombocytopenia"],"prefix":"10.1097","volume":"42","author":[{"given":"Priscila E.","family":"Kamioka","sequence":"first","affiliation":[{"name":"Pediatric Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadete L.","family":"Liphaus","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Investigation, Children\u2019s Institute, Faculty of Medicine, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia M.","family":"Beatrice","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy C.","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce M.A.","family":"Reis","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Investigation, Children\u2019s Institute, Faculty of Medicine, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Lima","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Investigation, Children\u2019s Institute, Faculty of Medicine, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda M.S.","family":"Carneiro-Sampaio","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Investigation, Children\u2019s Institute, Faculty of Medicine, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge D.A.","family":"Carneiro","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fimmu.2018.00880","article-title":"Emerging concepts in immune thrombocytopenia","volume":"9","author":"Swinkels","year":"2018","journal-title":"Front Immunol"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.autrev.2014.01.049","article-title":"The diagnosis and clinical significance of polyautoimmunity","volume":"13","author":"Anaya","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2014.06.015","article-title":"Autoantibodies in pre-clinical autoimmune disease","volume":"437","author":"Hu","year":"2014","journal-title":"Clin Chim Acta"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00043426-199707000-00006","article-title":"Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura","volume":"19","author":"Zimmerman","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11239-007-0031-y","article-title":"Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura","volume":"24","author":"Altintas","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/09537100801894651","article-title":"Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura","volume":"19","author":"Altintas","year":"2008","journal-title":"Platelets"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3109\/08916934.2010.506207","article-title":"Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66","volume":"43","author":"Zhang","year":"2010","journal-title":"Autoimmunity"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/08880018.2012.756564","article-title":"Prevalence and clinical significance of antithyroid antibodies in children with immune thrombocytopenic purpura","volume":"30","author":"Bay","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/pedi.12128","article-title":"Diabetes and immune thrombocytopenic purpura: a new association with good response to anti-CD20 therapy","volume":"16","author":"Tschudin","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jbspin.2016.11.012","article-title":"The autoimmune tautology. A summary of evidence","volume":"84","author":"Anaya","year":"2017","journal-title":"Joint Bone Spine"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.autrev.2015.01.017","article-title":"Autoantibodies 2015: from diagnbstic biomarkers toward prediction, prognosis and prevention","volume":"14","author":"Damoiseaux","year":"2015","journal-title":"Autoimmunity Rev"},{"key":"R14-20231002","first-page":"126","article-title":"Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients","volume":"30","author":"Aikawa","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1590\/S0482-50042007000600005","article-title":"Associa\u00e7\u00e3o de imunodefici\u00eancias prim\u00e1rias com doen\u00e7as auto-imunes na inf\u00e2ncia [Primary immunodeficiencies and autoimmune diseases association in childhood]","volume":"47","author":"Jesus","year":"2007","journal-title":"Rev Bras Reumatol"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1590\/S0482-50042007000100004","article-title":"P\u00farpura trombocitop\u00eanica e anemia hemol\u00edtica auto-imune em pacientes internados com l\u00fapus eritematoso sist\u00eamico juvenil [Thrombocytopenic purpura and autoimmune hemolytic anemia in hospitalized patients with juvenile systemic lupus erythematosus]","volume":"47","author":"Kim","year":"2007","journal-title":"Rev Bras Reumatol"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1590\/S0482-50042012000600015","article-title":"Anti-C1q, anti-chromatin\/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients","volume":"52","author":"Jesus","year":"2012","journal-title":"Rev Bras Reumatol"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.2337\/dc13-0425","article-title":"The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients","volume":"36","author":"Sosenko","year":"2013","journal-title":"Diabetes Care"},{"key":"R19-20231002","first-page":"e512","article-title":"Immune thrombocitopenic purpura and gastrites by H. pylori associated with type 1 diabetes mellitus","volume":"8","author":"Culquichic\u00f3n-S\u00e1nchez","year":"2016","journal-title":"Cureus"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajh.20299","article-title":"Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura","volume":"79","author":"Pratt","year":"2005","journal-title":"Am J Hematol"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2169\/internalmedicine.56.7506","article-title":"Autoimmune hepatitis associated with immune thrombocytopenic purpura","volume":"56","author":"Ito","year":"2017","journal-title":"Intern Med"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00535-011-0421-y","article-title":"Present status of autoimmune hepatitis in Japan: a nationwide survey","volume":"46","author":"Abe","year":"2011","journal-title":"J Gastroenterol"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"e5565","DOI":"10.1097\/MD.0000000000005565","article-title":"Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: a retrospective study","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T19:24:03Z","timestamp":1696274643000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,26]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001836","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,26]]}}}